Evidence Hub

A Case Report: Korean Medicine Treatment for Miller-Fisher Syndrome with Ophthalmoplegia

Hae-yoong Kim, Jeong-hui Kim, Seo-Young Won, Ho-ryong Yoo, In-chan Seol, Yoon-sik Kim

The Journal of Internal Korean Medicine, 2022

Abstract

The purpose of this case report was to document the efficacy of Korean medicine as a treatment for Ophthalmoplegia of Miller-Fisher Syndrome. A 57-year-old male patient was treated with acupuncture, electropuncture, pharmacopuncture, and cupping treatments for 2 months. Symptom changes were evaluated using the Scott and Kraft score, photographs of eyeball movement, and the Yanagihara score. Korean medicine treatment significantly improved the eye movements, ncreased the Scott and Kraft score from -4 to 0, and improved the Yanagihara score from 20 to 32. Korean medicine treatment could effectively and quickly treat Ophthalmoplegia of Miller-Fisher Syndrome.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free